Atika Capital Management LLC Cabaletta Bio, Inc. Transaction History
Atika Capital Management LLC
- $678 Million
- Q4 2024
A detailed history of Atika Capital Management LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Atika Capital Management LLC holds 1,000 shares of CABA stock, worth $2,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$2,060% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$9.8 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$8.39 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.49 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$5.91 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$5.69 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $59.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...